Possibilities of long-term effective treatment of idiopathic pulmonary arterial hypertension by replacing sildenafil with riociguat and using sequential combination therapy: case report

Modern pathogenetic therapy of idiopathic pulmonary arterial hypertension (IPAH), a severe life-threatening cardiovascular disease of unknown etiology, leads to a positive clinical effect due to reverse remodeling of the vessels of the microvasculature of the lungs. Highly effective drugs of specifi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	S. A. Musashaykhova, Z. S. Valieva, A. K. Osokina, I. Z. Korobkova, V. V. Gramovich, N. M. Danilov, T. V. Martynyuk
Médium:	Artigo
Jazyk:	Russo
Vydáno:	InterMedservice 2022-12-01
Edice:	Евразийский Кардиологический Журнал
Témata:	idiopathic pulmonary arterial hypertension specific therapy sildenafil riociguat ambrisentan selexipag case report
On-line přístup:	https://www.heartj.asia/jour/article/view/6353
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!